Of note, it has been demonstrated that lamin A mutations causing MADA or other progeroid laminopathies are also able to trigger TGFβ 2 signaling with downstream effects on mTOR pathway and osteoclastogenic activity [32]. Here, MTOR is linked to laminopathy.